Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study
暂无分享，去创建一个
M. Hurwitz | M. Sznol | A. Balar | D. Cho | A. Siefker-Radtke | J. Zalevsky | S. Currie | D. Chien | M. Tagliaferri | G. Grignani | N. Tannir | M. Bilen | A. Diab | U. Hoch | Erika G Puente | Lily Tang | D. Yu | Arkopal Choudhury